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Many professional and amateur sports including
track and field, weight-lifting, boxing, canoeing,
professional baseball and professional cycling have
suffered scandals involving steroids and human
growth hormone (HGH) and have done so for
many years.1–4 It seems self-evident that the use of
steroids and HGH is a problem. The amount of
media and political attention paid to steroids and
other pharmacological forms of enhancement in
sports, such as the use of blood doping and
stimulants, suggest that biochemical enhancement
is one of the greatest moral problems the world
faces.
Well, OK, upon deeper reflection, the challenge
of getting the steroids out of bicycle racing is not
on the same moral plane as eliminating poverty or
AIDS. Still, many people all over the world seem to
think that the latest generation of performance-
enhancing substances threatens the very integrity
of sport. There has been a burst of writing in recent
years making precisely this case and the budget and
clout of the World Anti-Doping Agency (WADA)
and similar policing agencies are growing, reflecting
the view that chemical enhancement and fair
competition cannot coexist.
In one sense, the argument that the current
techniques for enhancing sports performance
threaten sport is irrefutable. Synthetic steroids
are dangerous. HGH in large amounts can be too.
There is a real need to protect children who admire
athletes, so as to prevent them from taking serious
risks with their health in imitating what their idols
do or, in a few instances, from being forced by their
own parents to engage in risky behaviour in order
to succeed in athletics.
But, what if biomedical science could put the
safety issue aside? Someday, probably soon, there
will be drugs that do what steroids do without any
real risk of harm to the user. Forms of gene therapy
are also being developed that will let us safely
tweak ourselves and our offspring to perform
athletic feats that are ’’swifter, higher and stron-
ger’’ than ever before seen.5 6 Would the world still
want the interventions banned? Would doctors
who offered such techniques be acting immorally?
John Harris, a British bioethicist, thinks not. In
his book, Enhancing evolution,7 he argues that
performance enhancement is not only ethically
acceptable, but that it may be morally obligatory.
Harris sees a legitimate role for the use of drugs and
genetic engineering to improve performance in
sport. He contends, safety aside, there are no
convincing arguments against performance
enhancement.7
In Harris’s sports world, the genetically engi-
neered, chemically enhanced and optimally trained
should serve as our heroes. They will give us
performances we really will never forget. And that,
he argues, is the whole point of sport, so there is
nothing wrong with enhanced performance. Or is
there?
Harris’s defence of performance enhancement
stands in stark contrast to the efforts of sports
authorities, medical organisations and prosecutors
all over the world to vigorously chase down and
defrock of honours any athletes who have used
performance-enhancing substances. Are the prose-
cutions really persecutions? Should not adult
athletes be free to take the risks they want to take
in pursuit of their athletic goals? And when safety
goes off the table, should performance enhance-
ment simply be accepted as the future of sport? Are
those who want seconds shaved off the time it
takes to run a mile, high jumpers who can clear
3 metres, or baseball sluggers capable of smashing
100 or more home runs in a single season really all
that interested in whether these records can be
achieved without enhancement? There were few
complaints about the effect of the latest swimming
garb, as swimmers at the recent Olympics again
and again destroyed previous world records by
significant margins.8 Does sports medicine need
to get ready for a not so distant day when it
manages a thriving trade in performance-enhancing
substances?
Maybe Harris is wrong. Sports, contrary to his
view, involve more then seeing who performs best.
One of the most interesting critics of pharma-
cological enhancement in sport is Harvard political
scientist Michael Sandel, who has argued9 10 that
the causal role of human agency plays a key role in
substantiating our admiration of athletic perfor-
mance. In commenting on drug use in baseball he
observes that:
‘‘…as the role of (drug) enhancement increases,
our admiration for the new achievement fades—
or, rather, our admiration for the achievement
shifts from the player to his pharmacist’’.10
Sandel is clearly on to something when he argues
that chemically produced performance enhance-
ment undermines our willingness to esteem the
drug-addled performances of the recent winners of
the Tour de France or the track successes of a Ben
Johnson or a Marion Jones. Do we value a
connection between effort and outcome? I think
we do.
Every once in a while someone wins the lottery
or finds an old heirloom worth a lot of money in
the attic and no one seems to mind that they have
advanced themselves through luck, not exertion.
But that is not true in sport. A lucky bounce or a
gust of wind can determine the outcome, but
athletes get praise for performance linked to effort,
not simple luck. The whole point of sport is to try
to reward effort, even if luck also plays a crucial
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role in the outcome. Big efforts that produce big performances
get the praise; luck or fluke-driven performances just get
noticed.
Sports performances are explicitly associated, by the nature of
the rules governing the activity, with causal effort. Sport is
defined by its rules and most—admittedly as a matter of history
or culture—link effort and outcome. If someone simply takes a
pill and solely as a result can lift a lot of weight it may be
amazing. But it is only a weightlifter’s willingness both to train
and to show extraordinary effort under conditions similar to
those facing other weightlifters that makes weightlifting an
athletic achievement as opposed to an exhibition. Similarly, the
high-tech swim suits used in Beijing and other swimming
competitions in the past year do contribute to improved
performance but they do not obviate the need for serious,
sustained and strenuous training on the part of the swimmer.
Outcomes don’t define sport—the process leading to the
outcomes does.
But the ability of technology to improve performance, whether
by drugs on the engineering of equipment threatens the nature of
sport in a different way. Not only must performance-enhancing
technologies, whether biochemical, engineering or environmental
leave plenty of room for effort, they also cannot drive too large a
gap between the performances of the past and the performances
of today. Assessment of effort under relatively controlled
conditions provides the continuity that allows the comparison
of athletic performance between events, across national bound-
aries and over the years. That continuity helps distinguish a sport
from an exhibition. That is why short-circuiting one’s way to
success by pills or hormones or gene-tweaking undercuts the value
of athletic performance, because both effort and continuity are
required in sport to make it a sport. Performance A must be
assessable against performance B, achieved in a different time and
place, if we are to have a sport.
Every sport has its decisions to make about the affect of
equipment on continuity. Aerodynamic helmets in cycling, luge
or bob-sledding, more aerodynamic balls in golf, metal or
wooden bats in baseball, hydrodynamic oars in rowing, clapper
skates in ice-skating, LaZr suits in swimming, large-head
racquets in tennis, and carbon fibre composites in pole vaulting
are just some of the many engineering technologies that can so
affect performance as to make comparability and continuity
with previous performances impossible. Similarly, oxygen tents,
highly controlled diets, portable telemetry, improved weight-
training equipment and a greater understanding of psychology
may allow for environmental intervention that disrupts
comparability and continuity. There is no hard and fast answer
to how to handle this problem. Some sports are very sensitive to
any engineering or environmental intervention and resist them.
Others are more tolerant. But, the fact that sports struggle with
the continuity problem reveals the fact that it is important to
the nature of sport.
So perhaps sport can be saved from the next generation of
performance enhancing tricks or techniques by conceding that
sport is convention-bound and arbitrarily so but it is. Effort
leading to performance and the continuity of performances
across time are definitive of sport. Enhancement threatens to
undercut the emphasis on effort and continuity demanded by
the rules. Admittedly, engineering, environmental manipula-
tion, genetic alteration or drug-induced biochemical changes can
all undercut either effort or continuity, or both. Still, it is this
tension in deciding what enhancement to permit that ensures
the future of sport and promises some restriction over what
athletes can do, even if safety is not a concern. But there is one
more problem that modern science poses for sport and it has
nothing to do with enhancement.
The problem with putting one’s chips on continuity and
effort is that as biomedical knowledge of human capabilities and
aptitudes grows, sports asks us to value the random luck of the
genetic lottery of life that gives some people genes for strength,
others genes for superb vision and still others genes for unusual
coordination. The genetic lottery is not fair. If that is so then
why is the randomness that greatly determines what efforts
athletes are capable of making something to be admired?
We are learning more and more about the ways in which genes
and environment interact to produce behaviour, skills, talents and
aptitudes.11 Looking for value in the natural distribution of talents
and skills is like looking for the source of free will in the random
nature of evolution or the Heisenberg uncertainty principle.
Estimable value does not lurk in random luck. It is hard to see why
our increasing knowledge that it is heredity and early fetal
development that sets the table for performance will not undercut
sport. If at one end drug-enhanced or technology-driven
performance lurches toward becoming mere exhibition, then
understanding the genetic basis of human skills and capabilities
transforms sport into a version of aesthetics—something in which
performance can be admired as beautiful but not as estimable.
Strangely, the greatest threat in to the future of sport is not
necessarily new drugs, gene therapy or better chemistry. The
more knowledge we gain about the hereditary and developmental
factors involved, the greater the threat to our ability to value
performance as the result of anything other than random luck in
the distribution of the hereditary materials that govern so much
of what each person can achieve.12 Science does not destroy the
possibility of effort but it may diminish our understanding of its
role to the point where sport simply devolves into exhibition.
The good news for sports fans and doctors who assist athletes
is that there may be a moral rationale for limiting performance
enhancing drugs and techniques in sport. The bad news is that
the increasing knowledge of the genetics, biochemistry and
physiology of human abilities may make it difficult for sport to
long endure.
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